As the flagship journal of ESTRO we aim to publish the best science in the field of radiation oncology serving a multi-professional cancer community.
Joined June 2020
- Tweets 916
- Following 35
- Followers 3,962
- Likes 32
29 Photos and videos
15 Aug 2025
Our @LinkedIn account has now more than 5,000 users, growing >1,600 new followers in the last 3 months.
Subscribe to our account linkedin.com/showcase/greenj… to get regular updates on our publications and initiatives!
cc @PBlanchardMD
1
9
927
Radiotherapy & Oncology retweeted
27 May 2025
We’re moving our updates and conversations from Twitter X to LinkedIn! 🚀Follow us at TipsRO LinkedIn page linkedin.com/showcase/tipsro… to stay connected with the latest in technical innovations and patient support in radiation oncology. See you there! @ESTRO_RT @RO_GreenJournal
3
4
1,393
11 May 2025
🚀 Thrilled to announce 3 new clinical trials in Radiotherapy & Oncology in partnership with @TheLancetOncol Lancet Oncology):
✨ ESO-SPARE
🔍 DBCG IMN2 post-hoc
📊 FAST-Forward nodal sub-study
More details coming soon! 👀 #ESTRO2025 #GreenJournal
1
12
38
2,771
8 May 2025
We’re no longer posting here. Join us on LinkedIn for the latest updates! 📢
Catch our Editor-in-Chief Pierre Blanchard in a new interview on:
✨ The evolving role of journals
🤝 Cross-journal collaboration
🌱 Tips for early-career researchers
🔗 linkedin.com/feed/update/urn…
1
2
10
5,854
1 May 2025
We are really looking forward to this session! Can't wait to see you all there!
1 May 2025
A privilege to co-chair this @TheLancetOncol @RO_GreenJournal join session at #ESTRO2025 this weekend. See you there!
5
1,157
1 May 2025
📢 Don’t miss the Green Journal–Lancet Oncology joint plenary at #ESTRO2025!
🗓 Sun May 4 | ⏰ 11:40–12:45
📍 Plenary Hall
Top clinical trials in GI & SBRT from 🇬🇧 🇳🇱 🇨🇳 — including PLATO ACT 4, STAR-TREC, PRIME-RT & more.
#Radiotherapy #Oncology #GreenJournal
2
21
6,011
30 Apr 2025
👏 A heartfelt thank you to our top reviewers over the past year at Radiotherapy & Oncology (The Green Journal)!
Your expertise, time, and dedication help uphold the highest standards in our field.
We deeply appreciate your contributions.
#PeerReview #GreenJournal
1
2
21
4,305
29 Apr 2025
🔬 New in The Green Journal: RTQA matters.
This first meta-analysis links radiotherapy protocol deviations to worse survival in cancer trials.
OS HR=1.65, PFS HR=1.79.
Real-time QA could improve outcomes sciencedirect.com/science/ar…
#RTQA #Oncology #RadOnc
1
15
30
3,860
25 Apr 2025
📢 Just 1 week to go until #ESTRO2025!
The abstract book is live — have you found yours?
👉 user-swndwmf.cld.bz/ESTRO-20…
From AI to adaptive RT, this year’s programme is packed with innovation.
What sessions are you most excited for?
#RadiationOncology #ESTROabstracts
8
17
1,320
Radiotherapy & Oncology retweeted
21 Apr 2025
Stereotactic reirradiation for in-field lung cancer recurrence after stereotactic ablative radiotherapy - Kevin Jang (@kevjang_)
@RO_GreenJournal
oncodaily.com/science/kevin-…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #SABR #LungCancer #Radiotherapy
1
18
871
22 Apr 2025
🧠 New review sheds light on how to select and delineate post-op radiotherapy target volumes in oral cavity SCC. A must-read for H&N specialists
🔗thegreenjournal.com/article/…
#RadOnc #HeadandNeckCancer #OralCancer #Radiotherapy
22 Apr 2025
1st part of #Radiotherapy Series that deep dives into #PORT for #Headneckcancer
Thanks to @ESTRO_RT and Team led by Profs_Mererid & Vincent with superb colleagues @sueyom @PierluigiBonomo
Part 2 on delineation otw!
Must read for residents!
thegreenjournal.com/article/…
18
28
3,780
Radiotherapy & Oncology retweeted
21 Apr 2025
Pleased to share our latest work in @RO_GreenJournal
In-field lung re-SABR achieves excellent outcomes with low toxicities.
Size, dose, timing matters. Best results seen in recurrent tumours <2cm, cumulative BED ≥200 Gy, and interval >12 months.
thegreenjournal.com/article/…
2
9
18
1,370
21 Apr 2025
🔥 Can SABR work twice?
Meta-analysis shows in-field #SABR reirradiation offers 78% 1-year control with low toxicity—especially for small tumours, high BED (≥200 Gy), & long intervals.
💡 A safe, effective salvage option for recurrent #NSCLC.
📖 thegreenjournal.com/article/…
#radonc
20
49
3,918
16 Apr 2025
🤖 New in the Green Journal: Most radiation oncology patients support AI/ML in their care — but they want transparency, human connection, and equity.
📄 Read the study: sciencedirect.com/science/ar…
#RadiationOncology #AIinHealthcare #GreenJournal #SocietyMatters #ESTRO
1
4
10
1,259
14 Apr 2025
🌍 Society Matters — a new section in the Green Journal!
Exploring how radiation oncology intersects with climate, equity, policy & more.
📖 Read the first editorial: sciencedirect.com/science/ar…
💬 What should we cover next? #RadiationOncology #SocietyMatters #ESTRO #Sustainability
6
8
2,328
3 Apr 2025
🚨 New study in The Green Journal: Salvage #radiotherapy with VMAT shows promising outcomes for recurrent #ProstateCancer after #HIFU.
✅ Low toxicity
✅ No recurrences during follow-up
✅ A potential standard of care?
thegreenjournal.com/article/…
#Oncology
1
5
16
1,494
2 Apr 2025
🚨 Call for Papers! The 4 ESTRO journals are uniting for a landmark issue on reirradiation—a cutting-edge approach offering new hope to patients with recurrent cancers. Submit your research & help shape the future of cancer care! 🔗 thegreenjournal.com/content/… #Reirradiation #RadOnc
8
23
4,101
1 Apr 2025
📢 New ESTRO-EANO guideline in The Green Journal!
Recommendations for radiotherapy in IDH-mutant WHO grade 2 & 3 diffuse gliomas:
✅ Target volume delineation
✅ Imaging & planning techniques
✅ Dose & fractionation
A must-read for neuro-oncology teams!
thegreenjournal.com/article/…
29 Mar 2025
Check out the latest recommendations for contouring low-grade gliomas – with practical insights on volumes, OARs, and imaging integration.
A must-read for clinical practice and planning optimization.
#RadOnc #NeuroOncology #Contouring #RTplanning
⬇️⬇️⬇️
thegreenjournal.com/article/…
26
46
5,162
Radiotherapy & Oncology retweeted
25 Mar 2025
Investigator-initiated study sponsored by @JulesBordet and chaired by @AlexDeCaluwe and Laurence Buisseret.
Primary endpoint results presented at #ESMO24 oncologypro.esmo.org/meeting…
10 Mar 2025
🔬 The Neo-CheckRay trial explored pre-op immune-modulating SBRT (8 Gy x 3) immunotherapy in luminal B breast cancer, sparing tumor-draining lymph nodes to avoid immunosuppression. Feasible, but more research needed! thegreenjournal.com/article/…
#BreastCancer #RadiationOncology
3
8
954
24 Mar 2025
PSMA PET after radiotherapy: Timing matters! ⏳ In 217 lesions, uptake declined over time, lowest at 9–12 months. Prostate lesions showed prolonged uptake vs. lymph nodes/bone. Beware of pseudo-progression on early scans! 📉 Full study: sciencedirect.com/science/ar…
24 Mar 2025
Kinetics of PSMA PET signal after radiotherapy in 217 prostate cancer lesions: It takes multiple months for the uptake to decrease (> 6 months). Beware of "pseudo-progression" on PSMA PET performed shortly after RT. @RO_GreenJournal @masatoshihotta @UCLA
sciencedirect.com/science/ar…
25
53
4,060